The House Energy and Commerce Committee report, which is based on a two-year investigation led by GOP lawmakers, calls on Congress to amend laws governing Medicare's 340B drug discount program to improve transparency and bolster government oversight.
Other states have taken similar measures to fight the opioid misuse epidemic, in today's bite-sized hospital and health industry news from California, Florida, and Pennsylvania.
The Congressional Budget Office's latest estimates on CHIP reauthorization come as lawmakers—expected to vote on CHIP reauthorization legislation next week—debate how long the reauthorization should last.
When measles broke out in the Twin Cities' Somali community last spring, Children's Minnesota hospital deployed a rapid response strategy typically used for "large-scale disasters" to diagnose, contain, and treat those affected by the outbreak—and help reduce the chance of another one, Steven Ross Johnson reports for Modern Healthcare.
The Trump administration has suspended a national registry intended to provide information on evidence-based mental health and substance misuse programs, and plans to shift oversight of the review process for programs included in the database to an internal team.
Writing for the New York Times' "The Upshot," Dhruv Khullar, a physician and researcher, reflects on the role of "personal responsibility" in health care in the United States, contending that "[e]fforts to inject more personal responsibility into health care ... have not consistently been shown to lower costs, improve outcomes, or save lives."
Unfiltered water, known as "raw water," is a growing trend in the United States—but many experts warn that drinking water that has not been treated or filtered could be harmful and potentially lead to an outbreak of disease.
